NLRP3 inflammasome in atherosclerosis: Mechanisms and targeted therapies

被引：7
作者：
Chen, Pengfei [1 ]
Li, Xia [1 ,2 ]
机构：
[1] Shandong Univ, Marine Coll, Weihai, Peoples R China
[2] Shandong Kelun Pharmaceut Co Ltd, Binzhou, Peoples R China
来源：
FRONTIERS IN PHARMACOLOGY | 2024年 / 15卷
基金：
中国国家自然科学基金;
关键词：
NLRP3; inflammasome; atherosclerosis; mechanisms; targeted therapies; small molecule inhibitors; FOAM CELL-FORMATION; SMOOTH-MUSCLE-CELLS; ACTIVATION; APOPTOSIS; DISEASE; PATHOGENESIS; ASC; AUTOINHIBITION; INTERLEUKIN-1; INHIBITION;
D O I：
10.3389/fphar.2024.1430236
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Atherosclerosis (AS) is the primary pathology behind various cardiovascular diseases and the leading cause of death and disability globally. Recent evidence suggests that AS is a chronic vascular inflammatory disease caused by multiple factors. In this context, the NLRP3 inflammasome, acting as a signal transducer of the immune system, plays a critical role in the onset and progression of AS. The NLRP3 inflammasome is involved in endothelial injury, foam cell formation, and pyroptosis in AS. Therefore, targeting the NLRP3 inflammasome offers a new treatment strategy for AS. This review highlights the latest insights into AS pathogenesis and the pharmacological therapies targeting the NLRP3 inflammasome, focusing on optimal targets for small molecule inhibitors. These insights are valuable for rational drug design and the pharmacological assessment of new targeted NLRP3 inflammasome inhibitors in treating AS.
引用
收藏
页数：18
相关论文
共 50 条
[41]   Interaction between autophagy and the NLRP3 inflammasome [J].
Cao, Zhenrui ;
Wang, Yanhao ;
Long, Zhimin ;
He, Guiqiong .
ACTA BIOCHIMICA ET BIOPHYSICA SINICA, 2019, 51 (11) :1087-1095
[42]   The NLRP3 inflammasome in burns: a novel potential therapeutic target [J].
Li, Haihong ;
Zhao, Junhong ;
Cao, Leilei ;
Luo, Qizhi ;
Zhang, Cuiping ;
Zhang, Lei .
BURNS & TRAUMA, 2024, 12
[43]   NLRP3 Inflammasome Activation Controls Vascular Smooth Muscle Cells Phenotypic Switch in Atherosclerosis [J].
Burger, Fabienne ;
Baptista, Daniela ;
Roth, Aline ;
da Silva, Rafaela Fernandes ;
Montecucco, Fabrizio ;
Mach, Francois ;
Brandt, Karim J. ;
Miteva, Kapka .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (01)
[44]   NLRP3 inflammasome and NLRP3-related autoinflammatory diseases: From cryopyrin function to targeted therapies [J].
Moltrasio, Chiara ;
Romagnuolo, Maurizio ;
Marzano, Angelo Valerio .
FRONTIERS IN IMMUNOLOGY, 2022, 13
[45]   Atherosclerosis in ApoE-deficient mice progresses independently of the NLRP3 inflammasome [J].
Menu, P. ;
Pellegrin, M. ;
Aubert, J-F ;
Bouzourene, K. ;
Tardivel, A. ;
Mazzolai, L. ;
Tschopp, J. .
CELL DEATH & DISEASE, 2011, 2 :e137-e137
[46]   Atherosclerosis in ApoE-deficient mice progresses independently of the NLRP3 inflammasome [J].
P Menu ;
M Pellegrin ;
J-F Aubert ;
K Bouzourene ;
A Tardivel ;
L Mazzolai ;
J Tschopp .
Cell Death & Disease, 2011, 2 :e137-e137
[47]   An update on the regulatory mechanisms of NLRP3 inflammasome activation [J].
Paik, Seungwha ;
Kim, Jin Kyung ;
Silwal, Prashanta ;
Sasakawa, Chihiro ;
Jo, Eun-Kyeong .
CELLULAR & MOLECULAR IMMUNOLOGY, 2021, 18 (05) :1141-1160
[48]   NLRP3 inflammasome promotes diabetes-induced endothelial inflammation and atherosclerosis [J].
Wan, Zhaofei ;
Fan, Yan ;
Liu, Xiaojun ;
Xue, Jiahong ;
Han, Zhenhua ;
Zhu, Canzhan ;
Wang, Xinhong .
DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2019, 12 :1931-1942
[49]   Tanshinone IIA attenuates atherosclerosis via inhibiting NLRP3 inflammasome activation [J].
Wen, Jiexia ;
Chang, Yumei ;
Huo, Shanshan ;
Li, Wenyan ;
Huang, Heling ;
Gao, Yunhuan ;
Lin, Hongyu ;
Zhang, Jianlou ;
Zhang, Yonghong ;
Zuo, Yuzhu ;
Cao, Xuebin ;
Zhong, Fei .
AGING-US, 2021, 13 (01) :910-932
[50]   NLRP3 Inflammasome and Inflammatory Diseases [J].
Wang, Zheng ;
Zhang, Simei ;
Xiao, Ying ;
Zhang, Wunai ;
Wu, Shuai ;
Qin, Tao ;
Yue, Yangyang ;
Qian, Weikun ;
Li, Li .
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2020, 2020
12345